FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC under ANDA077691. The approval expands the available formulation/produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Familial Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

SUPPL AP for SIMVASTATIN (SIMVASTATIN)